We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+13.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.71B
AUM Growth
+$351M
Cap. Flow
-$22.1M
Cap. Flow %
-0.6%
Top 10 Hldgs %
21.85%
Holding
5,705
New
584
Increased
2,919
Reduced
1,681
Closed
462

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$127M
2
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$20M
3
PLTR icon
Palantir
PLTR
+$18.3M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$16.7M
5
DEO icon
Diageo
DEO
+$16.3M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$206M
2
META icon
Meta Platforms (Facebook)
META
+$37.5M
3
AMZN icon
Amazon
AMZN
+$35.5M
4
AVGO icon
Broadcom
AVGO
+$34.8M
5
MSFT icon
Microsoft
MSFT
+$29.8M

Sector Composition

Rank Sector Weight
1 Technology 20.47%
2 Financials 11.61%
3 Healthcare 8.42%
4 Industrials 6.72%
5 Consumer Discretionary 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NHI icon
1226
National Health Investors
NHI
$3.65B
$374K 0.01%
5,329
+3,150
+145% +$231K
MYY icon
1227
ProShares Short MidCap400
MYY
$2.88M
$373K 0.01%
19,915
+12,615
+173% +$252K
PRCH icon
1228
Porch Group
PRCH
$1.8B
$372K 0.01%
31,589
+22,185
+236% +$191K
WULF icon
1229
TeraWulf
WULF
$8.52B
$371K 0.01%
84,705
+76,035
+877% +$260K
TVTX icon
1230
Travere Therapeutics
TVTX
$5.78B
$370K 0.01%
24,998
+21,474
+609% +$356K
DORM icon
1231
Dorman Products
DORM
$4.18B
$370K 0.01%
3,015
+2,691
+831% +$327K
RNAM
1232
DELISTED
Avidity Biosciences
RNAM
$369K 0.01%
13,009
+4,850
+59% +$145K
ESI icon
1233
Element Solutions
ESI
$9.23B
$369K 0.01%
16,287
+13,619
+510% +$285K
URBN icon
1234
Urban Outfitters
URBN
$6.59B
$368K 0.01%
5,079
+3,498
+221% +$210K
CBU icon
1235
Community Bank
CBU
$3.41B
$368K 0.01%
6,474
+4,360
+206% +$242K
RBA icon
1236
RB Global
RBA
$17.5B
$368K 0.01%
3,464
-8,674
-71% -$889K
LW icon
1237
Lamb Weston
LW
$7.19B
$368K 0.01%
7,091
-1,695
-19% -$90.8K
CRNX icon
1238
Crinetics Pharmaceuticals
CRNX
$8.92B
$367K 0.01%
12,768
+12,235
+2,295% +$378K
PFGC icon
1239
Performance Food Group
PFGC
$18B
$367K 0.01%
4,198
+758
+22% +$63.1K
PPA icon
1240
Invesco Aerospace & Defense ETF
PPA
$8.7B
$367K 0.01%
2,591
-10,836
-81% -$1.37M
IBP icon
1241
Installed Building Products
IBP
$6.49B
$367K 0.01%
2,035
+1,455
+251% +$242K
NWE icon
1242
NorthWestern Energy
NWE
$4.43B
$367K 0.01%
7,148
+3,236
+83% +$179K
CYTK icon
1243
Cytokinetics
CYTK
$10.4B
$366K 0.01%
11,086
+2,551
+30% +$88.7K
BIIB icon
1244
Biogen
BIIB
$30.7B
$366K 0.01%
2,914
-5,311
-65% -$662K
TMDV icon
1245
ProShares Russell US Dividend Growers ETF
TMDV
$4.85M
$366K 0.01%
7,826
-6,135
-44% -$284K
EG icon
1246
Everest Group
EG
$14.4B
$366K 0.01%
1,076
-258
-19% -$89K
APGE icon
1247
Apogee Therapeutics
APGE
$10.2B
$366K 0.01%
8,419
+7,434
+755% +$283K
HSMV icon
1248
First Trust Horizon Managed Volatility Small/Mid ETF
HSMV
$39.5M
$365K 0.01%
10,193
-16,307
-62% -$577K
PSCC icon
1249
Invesco S&P SmallCap Consumer Staples ETF
PSCC
$41.7M
$365K 0.01%
10,979
-1,132
-9% -$38.9K
BNL icon
1250
Broadstone Net Lease
BNL
$4.02B
$365K 0.01%
22,722
+15,133
+199% +$242K
48 49
50
51 52

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2025 Portfolio in Review

As of Q2 2025, Tower Research Capital (TRC) held 5,705 positions worth $3.71B, up 10% from $3.36B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Tower Research Capital (TRC)'s Q2 2025 filing shows 584 new, 2,919 increased, 1,681 reduced and 462 closed positions. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M. The largest sale was Invesco QQQ Trust, an estimated $206M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Tower Research Capital (TRC)'s largest Q2 2025 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $127M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2025 reduction was Invesco QQQ Trust, cutting an estimated $206M.
  • Tower Research Capital (TRC) fully exited iShares S&P 500 Value ETF in Q2 2025, selling an estimated $6.43M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 22% of its $3.71B portfolio in Q2 2025.
  • Tower Research Capital (TRC) opened 584 new positions and closed 462 in Q2 2025.
  • Tower Research Capital (TRC)'s portfolio value rose 10% quarter-over-quarter to $3.71B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.